This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Pat Phillips
JAMA Contributor

JAMA. 1998;280:8-9.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

NEW DATA from the first prospective, randomized, large-scale trial of prostate cancer ever reported indicate screening in the general population may significantly decrease prostate cancer deaths.

"PSA testing saves lives," declared Fernand Labrie, MD, PhD, lead investigator of the Quebec Prospective and Randomized Study, and director of research at Laval University, Quebec. The 8-year study, begun in 1988, randomly divided 46193 men, ranging in age from 45 to 80 years, between screening and no screening. "There was a 69% decrease in deaths from prostate cancer in the group of men who were screened and treated early for prostate cancer at the time of diagnosis," said Labrie.

Labrie delivered the first presentation of the study findings at the plenary session of the annual meeting of the American Society of Clinical Oncology, held in Los Angeles, Calif, in May.

The study was immediately lauded by some physicians as "innovative" and . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?